| Term es nes pval sidak fdr geneset_size leading_edge leading_edge_size |
| Congenital generalized lipodystrophy cgl 0.928388017118396 3.639280219181973 0.0002734011651501 0.1543230336300371 0.0124969465287176 2 P31751 1 |
| Drug induction of bile acid pathway 0.8576319543509088 3.3076394579420394 0.0009408585332708 0.4384293952032879 0.0192248760298346 2 P08183 1 |
| Estrogen receptor pathway 0.8795080841338582 3.216327670680257 0.001298424882538 0.5490738189563668 0.0227409843713095 3 Q15067 1 |
| Zinc homeostasis 0.8353780313837391 3.2004042858202952 0.001372349416189 0.5690779076360475 0.0233680608923297 2 Q92504 1 |
| Vitamin d metabolism 0.8688579014358876 3.1666542334988033 0.0015420354902957 0.6117078752771369 0.0242803366568195 3 P04062 1 |
| Familial hyperlipidemia type 5 0.8268188302425126 3.158770635639396 0.0015843612826629 0.6216681870558817 0.0242803366568195 2 Q9UBV2 1 |
| Familial hyperlipidemia type 1 0.8268188302425126 3.158770635639396 0.0015843612826629 0.6216681870558817 0.0242803366568195 2 Q9UBV2 1 |
| Familial hyperlipidemia type 3 0.8268188302424887 3.1587706356392733 0.0015843612826635 0.6216681870560364 0.0242803366568195 2 Q8WTV0 1 |
| Irinotecan pathway 0.8213980028530465 3.1322891159050945 0.0017344898157596 0.6549843208326934 0.0259327379770891 2 O15118 1 |
| Acquired partial lipodystrophy barraquersimons syndrome 0.8837806967447105 2.9473129748806377 0.003205485896633 0.8602805689753443 0.0385286834242365 5 Q03252,O60725,P02545,P49354 4 |
| Striated muscle contraction pathway 0.8728622922483911 2.897589960356293 0.0037604187497861 0.9006872909216629 0.0419787800222181 5 P67936,P08670,P06753 3 |
| Nuclear receptors in lipid metabolism and toxicity 0.7740370898715786 2.8970873704154347 0.0037664484522381 0.9010550753201572 0.0419787800222181 2 P08183 1 |
| Metabolic pathway of ldl hdl and tg including diseases 0.799915694407997 2.837416009140743 0.0045480310988532 0.9388424634656832 0.0464657177266175 3 Q8WTV0 1 |
| Serotonin and anxiety 0.7594864479315294 2.8234085534744584 0.0047515978850731 0.9460485959468896 0.0477496639926206 2 Q06787 1 |
| Glycosaminoglycan degradation 0.8691696002216066 2.781739308914415 0.0054068451862498 0.9639694735057586 0.0494770448789923 6 P06865,P54802,P15586,P08236 4 |
| Sphingolipid metabolism integrated pathway 0.8372491803067044 2.776871853859672 0.0054884813242601 0.965737568091741 0.0494770448789923 8 O95470,Q96G23,P27544,Q13510,Q06136,O15269 6 |
| Sphingolipid metabolism overview 0.8372491803067044 2.776871853859672 0.0054884813242601 0.965737568091741 0.0494770448789923 8 O95470,Q96G23,P27544,Q13510,Q06136,O15269 6 |
| Arachidonate epoxygenase epoxide hydrolase 0.7323823109843117 2.6843311441976345 0.0072675083998652 0.9885669823368692 0.0530355077275879 2 P20674 1 |
| Familial hyperlipidemia type 2 0.7323823109843117 2.6843311441976345 0.0072675083998652 0.9885669823368692 0.0530355077275879 2 P01130 1 |
| Overlap between signal transduction pathways contributing to lmna laminopathies 0.6540202476093543 2.5997863257339056 0.0093281823220556 0.9968013066516044 0.063154845047534 16 P02545,O75844,P55209,P50402,O60725 5 |
| Metabolism of spingolipids in er and golgi apparatus 0.787935039557354 2.5980548311166736 0.0093753522011836 0.9968933210260384 0.063154845047534 4 Q06136,O95470 2 |
| Il10 antiinflammatory signaling pathway 0.806789404596258 2.5900856854071694 0.0095952045397955 0.9972885209795768 0.0639332650314639 5 P09601 1 |
| Cellular proteostasis 0.7747644875820673 2.534267206777258 0.0112682770183998 0.9990381636276536 0.0710306171763547 4 Q9UHV9,Q9NQP4,Q99471 3 |
| Influence of laminopathies on wnt signaling 0.7394370541159849 2.5306082412271205 0.0113864946195683 0.99910614221566 0.0710306171763547 11 O75844,P02545,P50402,O60725 4 |
| Degradation pathway of sphingolipids including diseases 0.8103399028849001 2.5096317403518498 0.0120857125359141 0.9994206910019504 0.0721973190982565 6 P06280,O43681,P06865,P16278,P17900 5 |
| Proteasome degradation 0.4604084650226395 2.4822441221897966 0.0130557796912154 0.9996827740100656 0.0747961958010751 41 O43242,P46934,P60900,P48556,P49720,Q99436,P28070,P28066,P04439,P49721,P10321,P20618,O00231,P28074,P25787,P25788,P28072 17 |
| Mitochondrial complex iii assembly 0.7552271771832808 2.4480225868894756 0.0143642650556385 0.9998593375453352 0.0800481316282405 9 Q6DKK2,O14949,Q9UDW1 3 |
| Triacylglyceride synthesis 0.7458971064532361 2.3927371183897734 0.0167232182590553 0.9999676215742638 0.0915297570785795 4 Q9HCL2 1 |
| Familial partial lipodystrophy fpld 0.7578229516623783 2.387884233603276 0.0169456787055415 0.99997181502367 0.0919265579336014 8 P49354,P02545,O75844,Q03252,O60725,P31751 6 |
| Familial hyperlipidemia type 4 0.7053467896702654 2.3628782399558035 0.0181336263230935 0.9999865688519324 0.0949061801312898 3 Q9UBV2 1 |
| Oxidation by cytochrome p450 0.749922566476989 2.3160712282801574 0.0205543799399392 0.999997042386944 0.0999986897077996 5 O43169 1 |
| Sphingolipid pathway 0.7280103517803889 2.3079184665514765 0.0210036717580333 0.9999977674993148 0.1009048182238673 9 P04062,O95470,Q96G23,Q13510,Q06136,O15269 6 |
| Ccl18 signaling pathway 0.7132568182511145 2.30673051761246 0.0210698478509869 0.9999978581184288 0.1009048182238673 10 P08670,P07196,P00403,P11166 4 |
| Phase i biotransformations non p450 0.6854133721545873 2.259324292359541 0.0238632198985988 0.999999628426286 0.1091653268495604 3 Q15165 1 |
| Mitochondrial complex iv assembly 0.6983513554133653 2.226909288474995 0.0259533369415094 0.999999900139294 0.1136385396081807 10 P14406,P00403,Q9Y2R0,Q7KZN9 4 |
| Kennedy pathway from sphingolipids 0.7257471180770819 2.1969107633952474 0.0280268199930602 0.9999999729557756 0.1193086156649022 5 O95470,Q9UG56,P35790 3 |
| Cholesterol biosynthesis with skeletal dysplasias 0.7424296790127978 2.184396442097537 0.0289331294432513 0.9999999847341342 0.1214795092377607 6 Q15125,Q15392,Q16850 3 |
| Relationship between inflammation cox2 and egfr 0.7156992727998409 2.146917243340765 0.0317998705882365 0.9999999975075378 0.1290948388780727 5 P31751 1 |
| Progeriaassociated lipodystrophy 0.6827710979959466 2.142743735142457 0.0321336814672683 0.9999999979824422 0.1295917548647072 10 P49354,P02545,O75844,Q03252,O60725 5 |
| Sphingolipid metabolism in senescence 0.6516546248450423 2.131463526703475 0.0330509741528601 0.9999999988717776 0.1314129979397234 12 P04062,Q96G23,P42345,P16278,Q13510,Q06136,O15269 7 |
| Statin inhibition of cholesterol production 0.7062129989867727 2.099467469835474 0.0357757125101887 0.9999999997999424 0.1379277469732433 5 P01130,Q8WTV0,P37268 3 |
| Arrhythmogenic right ventricular cardiomyopathy 0.6284721863231351 2.092104849237945 0.0364291374737084 0.9999999998679668 0.1390851817772206 13 O43707,P02545,P50402 3 |
| Interleukin1 induced activation of nfkb 0.6535055619026633 2.0909816011398115 0.0365297133215865 0.9999999998761508 0.1390851817772206 3 Q13501 1 |
| 15q112 copy number variation syndrome 0.7010279840091297 2.073430167931567 0.0381322637826249 0.999999999955361 0.142372593794324 5 Q96CW5,Q06787,Q7L576,Q9BSJ2 4 |
| Nanomaterial induced apoptosis 0.7150214468729544 2.049742526403168 0.0403895627561707 0.9999999999894268 0.1449732434125214 6 O95831,O43464 2 |
| Alzheimers disease 0.3622949774239382 2.0459667163850455 0.0407596454517882 0.9999999999916532 0.1449732434125214 87 O43242,P60900,P45880,P49720,P28070,P07437,P49721,P20618,P04350,P68371,Q9BUF5,Q9BVA1,O95197,P33176,P21796,P28072,P28066,Q13509,P28074,P25788,P48556,P42345,Q99436,Q9NQC3,P05198,P31751 26 |
| Alzheimers disease and mirna effects 0.3614944620037648 2.044399006679524 0.0409141453676447 0.999999999992438 0.1449732434125214 88 O43242,P60900,P45880,P49720,P28070,P07437,P49721,P20618,P04350,P68371,Q9BUF5,Q9BVA1,O95197,P33176,P21796,P28072,P28066,Q13509,P28074,P25788,P48556,P42345,Q99436,Q9NQC3,P05198,P31751 26 |
| Gdnfret signaling axis 0.6369863013698557 2.0025925252807224 0.0452210428315491 0.9999999999995208 0.1549158631533161 3 O94813,P35222 2 |
| Proteoglycan biosynthesis 0.685958669407031 1.9973514646041743 0.0457870163367744 0.9999999999996668 0.1549158631533161 5 Q8NCH0 1 |
| Omega3 omega6 fatty acid synthesis 0.6853010661016483 1.9940178574798255 0.0461501030236473 0.9999999999997362 0.1549158631533161 5 Q15067 1 |
| Neuroinflammation 0.6847335223703079 1.9911398815312165 0.046465510988473 0.9999999999997846 0.1549158631533161 5 P00403 1 |
| Pregnane x receptor pathway 0.6862884566952672 1.906541786231841 0.0565799496454477 0.9999999999999996 0.1773626657629747 6 P08183 1 |
| Aryl hydrocarbon receptor pathway wp2873 0.6644985861829928 1.8879853316827668 0.0590279196731873 1.0 0.181829722410371 5 Q16543,Q15185 2 |
| Electron transport chain oxphos system in mitochondria 0.3642367113205956 1.8774766417152988 0.0604527958306524 1.0 0.1843659892745768 53 P00403,O14949,Q9UDW1,O75964,P21912,P13073,P06576,Q7KZN9,O43676,P14406,P00846,P03886 12 |
| Nephrotic syndrome 0.5785635413102959 1.7898657469282455 0.073475496543977 1.0 0.2134619875898478 13 O75844,P02545,Q14108,O43707 4 |
| Mammary gland development pathway embryonic development stage 1 of 4 0.5671897289586293 1.783187353632342 0.0745558103898134 1.0 0.2142376722972235 2 P23229 1 |
| Adipogenesis 0.5441779105991551 1.768788397727731 0.0769291936807965 1.0 0.218322202436705 15 O75844,O75376,P02545,P14174 4 |
| Intracellular trafficking proteins involved in cmt neuropathy 0.6094780124717187 1.737188297744702 0.0823539398070187 1.0 0.2225551313007173 10 P07196,Q9NR77 2 |
| Allograft rejection 0.6165198064345012 1.7117018266438822 0.0869516318286491 1.0 0.2317450013520084 9 P08183,P08670,P04439,P10321 4 |
| Amyotrophic lateral sclerosis als 0.577949308704615 1.6985249744924589 0.0894087231418327 1.0 0.2346442988694895 12 P07196,P07197,Q9BUN8 3 |
| Insulin signaling in adipocytes normal condition 0.610507881522806 1.6976672586623351 0.0895705806451232 1.0 0.2346442988694895 4 P31751 1 |
| Insulin signaling in adipocytes diabetic condition 0.610507881522806 1.6976672586623351 0.0895705806451232 1.0 0.2346442988694895 4 P31751 1 |
| Transcription factors regulate mirnas related to cardiac hypertrophy 0.599345816706498 1.6382206320295325 0.1013756771810252 1.0 0.2589303754665353 4 Q9P2K5,P31751 2 |
| Glycerophospholipid biosynthetic pathway 0.5915283650913511 1.573613552450508 0.1155768181757084 1.0 0.2811451965940844 9 O15228,Q9Y6K0,Q9BTU6,Q9HCL2,O95674 5 |
| Proximal tubule transport 0.5667545743475644 1.5594437952246902 0.1188913775263917 1.0 0.2846891188424928 11 P08183,Q9Y5K8,P11166 3 |
| Nocgmppkg mediated neuroprotection 0.6074014010351919 1.55101061625671 0.1208991398365459 1.0 0.2883703218669365 7 P07196,Q13555 2 |
| Photodynamic therapyinduced nfe2l2 nrf2 survival signaling 0.6121785616301805 1.5284332229471465 0.1264050113697914 1.0 0.2993241339298104 6 P09601 1 |
| Peroxiredoxin 2 induced ovarian failure 0.5468036529680258 1.506401111163746 0.1319642356327652 1.0 0.3075820397067875 3 P32119,Q9UGN5 2 |
| Ferroptosis 0.4380658307144489 1.498991035960084 0.1338759575612671 1.0 0.3096828754153085 23 P37268,P09601 2 |
| Mecp2 and associated rett syndrome 0.4286651627661 1.4894120257594898 0.1363789037658813 1.0 0.3142867218364107 24 P42345,P67809,Q99640,P52597,P35637,O75376,P31943 7 |
| Extracellular vesiclemediated signaling in recipient cells 0.5417536468944184 1.4780294136370395 0.139399905525166 1.0 0.3200454759809991 3 P42345 1 |
| Disruption of postsynaptic signaling by cnv 0.5673136868235422 1.4386331177005771 0.150254498033763 1.0 0.3411333603507286 9 Q7L576,Q06787,Q13555,Q07157,Q14168 5 |
| Sleep regulation 0.5596071530850817 1.4245144054156738 0.1542976180528072 1.0 0.3464631496936662 4 P00813 1 |
| Inclusion body myositis 0.5221974100600524 1.3677384592916062 0.1713939569851876 1.0 0.3779298404025901 3 Q92542 1 |
| Mammary gland development pathway pregnancy and lactation stage 3 of 4 0.5496956045313728 1.2857086274809288 0.1985447691310671 1.0 0.4255522499207837 5 P06753 1 |
| Primary focal segmental glomerulosclerosis fsgs 0.4396116085890263 1.235750482370515 0.2165513263474023 1.0 0.4557683617818379 18 O43707,P35579,P08670,Q14108 4 |
| Endothelin pathways 0.5166384769649528 1.2056352191831965 0.2279581731678357 1.0 0.4674195387230182 10 P42892 1 |
| S1p receptor signal transduction 0.5344846848721685 1.2055502975501955 0.2279909332433645 1.0 0.4674195387230182 8 Q13510 1 |
| Bile acids synthesis and enterohepatic circulation 0.5183172306755821 1.2001008299741525 0.2301001832626517 1.0 0.4701713744666849 4 P51114 1 |
| Angiopoietinlike protein 8 regulatory pathway 0.3521428661813244 1.1638450201120096 0.2444868237757926 1.0 0.4908003969124591 33 Q13131,P42345,O00767,O14654,O75955,Q9UPT5,P54619,O00443,P31751,P51812,P46108,P11166 12 |
| Ciliopathies 0.4105703681319396 1.1625801904976825 0.2449998718682096 1.0 0.4908003969124591 21 Q10713,Q13432,Q9UBB4,Q15051,Q15555,O43924 6 |
| Nonalcoholic fatty liver disease 0.3071561882592435 1.1535461519712908 0.2486862858130534 1.0 0.4965364308066081 53 Q13131,P00403,O14949,Q9UDW1,P21912,P13073,O43674,O43676,O96000,P14406,Q9P0J0,P22695,P05198,P31751,Q9Y6M9 15 |
| Tyrobp causal network in microglia 0.5295780656149546 1.0972470576338138 0.2725334073222401 1.0 0.527012551067928 6 A0AV96,O15439,Q15418,Q5T1M5 4 |
| Caloric restriction and aging 0.4988667756184765 1.0941410586160478 0.2738931172681722 1.0 0.5279763549855018 4 P43490 1 |
| Synaptic signaling pathways associated with autism spectrum disorder 0.4819737275504384 1.0575608502071956 0.2902556989950082 1.0 0.55256752634764 11 Q13131,P42345,P31751,P21359 4 |
| Vitamin b12 disorders 0.4626141552511343 1.0297776441780324 0.3031143974734229 1.0 0.569966643101866 3 Q99707,P22033 2 |
| Il9 signaling pathway 0.4946287496309993 0.9871655384218108 0.3235614929410459 1.0 0.5974192625688589 8 P50750 1 |
| Inhibition of exosome biogenesis and secretion by manumycin a in crpc cells 0.4933702045638543 0.9803012158920236 0.326937454719161 1.0 0.6018398190475848 8 P31943,P61020,P20339 3 |
| Photodynamic therapyinduced nfkb survival signaling 0.4262482168331049 0.9560057112792356 0.3390693490376977 1.0 0.6167641274780673 2 P19838 1 |
| Altered glycosylation of muc1 in tumor microenvironment 0.4262482168331049 0.9560057112792356 0.3390693490376977 1.0 0.6167641274780673 2 P19838 1 |
| Camkk2 pathway 0.4485100113515531 0.912310102341864 0.3616054977847103 1.0 0.6425048409913837 12 O76024,P42345,P09601,Q13501,Q9Y3D6 5 |
| Glycogen synthesis and degradation 0.3918675055923947 0.8883420233072598 0.3743568013710574 1.0 0.6556591978298806 18 P46976,P06737,P46020 3 |
| Regulatory circuits of the stat3 signaling pathway 0.463289107531092 0.855619009651891 0.3922085516040245 1.0 0.681087371482343 9 P42345,P16949 2 |
| Nuclear receptors metapathway 0.2874747134068415 0.84100632800422 0.4003443893721536 1.0 0.6912989033383949 51 P08183,P30043,Q86UP2,P09601,Q15043,P23786,Q13501,Q16543,P11802,O15439,Q9HCL2,Q15067,P11166,Q92504 14 |
| Supression of hmgb1 mediated inflammation by thbd 0.4263698630136845 0.8261152949219065 0.4087386921898566 1.0 0.701839827205552 3 P09429,P19838 2 |
| Regulation of wnt bcatenin signaling by small molecule compounds 0.4237834221301916 0.8117546055413651 0.4169324544140549 1.0 0.7129514556716543 3 P48729 1 |
| Genes related to primary cilium development based on crispr 0.420518372632821 0.8018387629288469 0.4226462327754492 1.0 0.7156965212468243 13 Q8IW35,Q10713,O95684 3 |
| Pi3kaktmtor signaling pathway and therapeutic opportunities 0.4542911573195345 0.7797827077723897 0.435518786400898 1.0 0.7314329207226041 5 O75143,P42345,Q15118 3 |
| Liver x receptor pathway 0.391440798858782 0.753450097453638 0.4511794879430768 1.0 0.7479827225430293 2 O00767 1 |
| Development of ureteric collection system 0.4628497960040754 0.7523193208007292 0.4518590515996805 1.0 0.7479827225430293 6 O94813,Q5SZK8 2 |
| Physicochemical features and toxicityassociated pathways 0.3695926951276375 0.7299648084368646 0.465411695890692 1.0 0.7607929855493178 18 P07196,P07197 2 |
| Circadian rhythm genes 0.2879650370196858 0.7252403296449705 0.4683046052854469 1.0 0.7630386203777861 46 Q13131,P43490,Q14103,Q8WXF1,P00813,O75376,Q15233,P54802,P23246 9 |
| Pkcgamma calcium signaling pathway in ataxia 0.4043949771689339 0.7052454466291302 0.4806575034920068 1.0 0.7753764464226321 3 P29992,Q15118 2 |
| Cholesterol metabolism with bloch and kandutschrussell pathways 0.3331131519474836 0.6928061664815698 0.4884312018555641 1.0 0.7837914312498974 24 P37268,Q16850,Q15392,Q15125,Q15800 5 |
| Small cell lung cancer 0.3704833335455647 0.6783876402024392 0.4975259436947601 1.0 0.7963013145819529 16 P19838,P23229,P24941,P11802,Q16611,P31751 6 |
| White fat cell differentiation 0.3746077032810346 0.6579840609000704 0.5105483732588572 1.0 0.8107098046910732 2 P35221 1 |
| Regucalcin in proximal tubule epithelial kidney cells 0.4435996979854062 0.6560088580165963 0.5118184248212811 1.0 0.8107098046910732 6 P42345,Q16611 2 |
| Translation factors 0.2945268436134909 0.6481991759211092 0.5168561348551153 1.0 0.8165794089334681 37 O75822,Q9H074,Q14152,O15372,P23588,O75153,P05198,P29692,P60228,Q05639,P55010 11 |
| Interactions between immune cells and micrornas in tumor microenvironment 0.371754636233959 0.6420328165195799 0.5208518757337119 1.0 0.8186723072429882 2 P19838 1 |
| Ncrnas involved in stat3 signaling in hepatocellular carcinoma 0.371754636233959 0.6420328165195799 0.5208518757337119 1.0 0.8186723072429882 2 P19838 1 |
| Hostpathogen interaction of human coronaviruses autophagy 0.4246145059965616 0.6284073533108125 0.5297371212326314 1.0 0.8305085813698289 5 Q9NT62,O75143,P42345,Q99570 4 |
| Ketogenesis and ketolysis 0.4313089890324648 0.6204859807720813 0.5349378809972776 1.0 0.8365227577840081 7 O43772,P23786,P53985 3 |
| 1q211 copy number variation syndrome 0.4082199179963526 0.593129558381591 0.5530944502221797 1.0 0.8605251217923761 10 Q13131,Q16625,P35222,P54619,Q9UDY2,Q07157 6 |
| Network map of sarscov2 signaling pathway 0.2957362877839851 0.5907016899605175 0.5547203154372866 1.0 0.8608697553495106 28 Q08380,P42345,Q9P253,Q9H269,Q6PKG0,Q96AX1,Q96J02,P31350,P06493,Q07021,O95067 11 |
| Id signaling pathway 0.3603423680456568 0.5790262179695819 0.5625714827130361 1.0 0.8664731630730934 2 P24941 1 |
| Joubert syndrome 0.3280790041940039 0.5710237436357595 0.5679835480488973 1.0 0.8680348042585811 22 Q10713,Q13432,P41208,Q15154,O43924 5 |
| Nrf2 pathway 0.3173252579650505 0.5684969644005248 0.5696975663531527 1.0 0.8680348042585811 24 P30043,Q15043,P09601,O15439,P11166,Q92504 6 |
| Eicosanoid metabolism via lipooxygenases lox 0.4253499363343661 0.5670714754512793 0.570665621723015 1.0 0.8680348042585811 6 O15254,Q15067 2 |
| Extracellular vesicles in the crosstalk of cardiac cells 0.3718607305935983 0.5329556153312819 0.5940643051051548 1.0 0.8860375158867638 3 Q96HC4,P04792 2 |
| Apoptosis modulation and signaling 0.3306716929201666 0.522329028520769 0.6014412611443825 1.0 0.890544349101168 20 Q13546,P98170,Q07820,Q9NR28,O95831,O43464,O76075,Q16611 8 |
| Neural crest cell migration during development 0.3929042701898326 0.5126111217139396 0.6082233718905232 1.0 0.8941029423714407 10 Q8N5V2,P31751 2 |
| Fas ligand pathway and stress induction of heat shock proteins 0.3313282836608168 0.4717515737216725 0.6371041201849152 1.0 0.9253649039524694 18 Q03252,P02545,P20700 3 |
| Autophagy 0.3885064150497252 0.4613168721240461 0.6445712817666374 1.0 0.9253649039524694 9 Q13131,P42345,P54619 3 |
| P53 transcriptional gene network 0.3923873392304308 0.454993321449092 0.6491140435555658 1.0 0.9253649039524694 8 P04066,P11166 2 |
| Complement system in neuronal development and plasticity 0.3585960694586124 0.4399315212013062 0.6599867051917789 1.0 0.9365089126911122 13 Q9NR28,P98170,Q5KU26,O43464 4 |
| Endometrial cancer 0.352693647835926 0.4081843518671069 0.683138335557667 1.0 0.9458266646640848 13 P31751 1 |
| Mitochondrial complex i assembly model oxphos system 0.2735351499546098 0.4055563872733105 0.6850685792999245 1.0 0.9458266646640848 29 Q8TB37,Q8IUX1,Q9NPL8,Q7L592,O43674,O43676,O96000,Q9P0J0,P51970,P03886,Q96CU9,Q9Y6M9 12 |
| Pdgf pathway 0.3189792919056485 0.3942764670444165 0.6933769356168826 1.0 0.9487501373507792 18 P00403,P62993 2 |
| Neural crest cell migration in cancer 0.3628720037346634 0.3910674191588913 0.6957474025199504 1.0 0.9498734025495092 11 Q8N5V2,P31751 2 |
| Genes controlling nephrogenesis 0.3858897457869136 0.3860841186294818 0.6994343712320199 1.0 0.9506724380603728 6 P35222,P05556,Q9Y5K6,O94813,P11047 5 |
| Ciliary landscape 0.2369501772445136 0.3784692972964446 0.7050819977252929 1.0 0.9550773772477014 115 P06280,Q9NTJ3,Q9UBW8,P08670,Q9BT78,O43464,P07197,P46937,P07196,Q14566,Q15051,P10619,O43805,A0AVF1,Q9Y4W6,P61201,Q9UPT5,Q96P70,P17844,O95400,P16278,Q15555,P48556,A5YKK6,Q92905,O15173,Q8IW35,O75663,P49736,Q92600,Q9Y266,Q96A65 32 |
| Wntbetacatenin signaling pathway in leukemia 0.3594062232372192 0.3772614470632089 0.7059793198107163 1.0 0.9550773772477014 4 P48729,P14923,P35222 3 |
| Type i collagen synthesis in the context of osteogenesis imperfecta 0.3446833821813675 0.3661706521069255 0.7142377399316622 1.0 0.9581544863828736 13 Q32P28,P13674,P07237,O75718,O15460 5 |
| Cardiac hypertrophic response 0.3290775101343336 0.3660638178848507 0.7143174555904945 1.0 0.9581544863828736 15 P31751 1 |
| Eicosanoid metabolism via cyclooxygenases cox 0.376136379402873 0.3444585381658624 0.730501472046057 1.0 0.9734726138352888 6 O15254,Q15067 2 |
| G1 to s cell cycle control 0.2637103277221519 0.32921544890603 0.7419928466721699 1.0 0.9820873077951786 30 P33991,Q99640,Q14566,P11802,P49736,O75419,P06493,Q9Y619 8 |
| Factors and pathways affecting insulinlike growth factor igf1akt signaling 0.3599199542595677 0.3273880470037931 0.7433744059004288 1.0 0.9820873077951786 9 P42345,Q96B36,P19838,Q13418,P05556,P06730,P49770,Q15118 8 |
| Autosomal recessive osteopetrosis pathways 0.3278722818321604 0.3211070363288604 0.7481292782269593 1.0 0.9841271406719444 3 P51798 1 |
| Rac1pak1p38mmp2 pathway 0.2985576128635139 0.2932467847282147 0.7693335260363101 1.0 0.9908534227025164 19 P46937,P62993 2 |
| Nsp1 from sarscov2 inhibits translation initiation in the host cell 0.325964056867959 0.2734551851616402 0.7845033369640069 1.0 0.9908534227025164 13 O75822,O15372,P05198,P60228,P55010 5 |
| Regulation of apoptosis by parathyroid hormonerelated protein 0.3551196765125398 0.272731033883701 0.7850599771368358 1.0 0.9908534227025164 7 Q16611,Q07820,Q9BXK5 3 |
| Spinal cord injury 0.283947220117587 0.2718647841745349 0.7857259898489 1.0 0.9908534227025164 22 P17931,P24941,Q08209,Q9NQC3,P08670,P11802,P06493,P14174 8 |
| Ebola virus infection in host 0.2479821557329014 0.2666028867227689 0.7897749327793866 1.0 0.9908534227025164 41 P46934,O15118,Q9H269,P12814,Q96AX1,P10321,P05198,Q9P253,Q07021,O43707 10 |
| Head and neck squamous cell carcinoma 0.3085327358705012 0.2577490632983394 0.796600578009123 1.0 0.9908534227025164 15 Q13131,P42345,P31751 3 |
| Epithelial to mesenchymal transition in colorectal cancer 0.2811171286916223 0.2548588827681105 0.7988320945695222 1.0 0.9908534227025164 22 P62993,P31751 2 |
| Metapathway biotransformation phase i and ii 0.2791188331326216 0.2430458523214768 0.807969877149836 1.0 0.9911982910299018 22 Q8NCH0,Q16850 2 |
| Bdnftrkb signaling 0.342792497138684 0.2382927968946225 0.8116540077104482 1.0 0.9911982910299018 8 P62993 1 |
| Embryonic stem cell pluripotency pathways 0.3283649844423338 0.2323346810071145 0.8162780777448362 1.0 0.9911982910299018 11 P31751 1 |
| 7oxoc and 7betahc pathways 0.3324979112703353 0.2299200846578157 0.8181538690763177 1.0 0.9911982910299018 10 O15118 1 |
| Preimplantation embryo 0.3405396532713625 0.2295459579722291 0.8184446047402143 1.0 0.9911982910299018 8 Q99729 1 |
| Srebf and mir33 in cholesterol and lipid homeostasis 0.3379952794210637 0.2074475205580574 0.8356603736280341 1.0 0.9911982910299018 7 P01130,Q13131 2 |
| Pathogenic escherichia coli infection 0.2516086942003132 0.2057989597861562 0.8369479537793658 1.0 0.9911982910299018 27 Q16625,Q13509,P07437,P04350,P68371,Q9BUF5,Q9BVA1 7 |
| Copper homeostasis 0.3320943362122101 0.1977527287512143 0.843238532678527 1.0 0.9911982910299018 8 O75880,P98170,Q04656 3 |
| Melanoma 0.2837929531966164 0.184908862826744 0.853300519337189 1.0 0.9911982910299018 17 P11802,Q13153,Q16611,P62993,P31751 5 |
| Vitamin d receptor pathway 0.3041201340661735 0.1766808903339138 0.8597590520239129 1.0 0.9911982910299018 13 P08183 1 |
| Insulin signaling 0.2300341473910961 0.1724395519562335 0.8630919799001568 1.0 0.9911982910299018 48 Q9H4M9,Q13131,P42345,O14654,O75955,P46976,P33176,P62993,O00443,P31751,P51812,P46108,P11166 13 |
| Glial cell differentiation 0.2670470756062862 0.1463303434557806 0.8836606130527631 1.0 0.9911982910299018 2 P26038 1 |
| Interactions between loxl4 and oxidative stress pathway 0.2974057635424263 0.1368799279437401 0.8911257046680037 1.0 0.9911982910299018 4 Q16543 1 |
| 16p112 distal deletion syndrome 0.3071446913393409 0.1230608010228354 0.9020589515358232 1.0 0.995529969587646 9 P62993,Q9UJ41 2 |
| Dna replication 0.2323717079942656 0.1143961993649977 0.9089237266862492 1.0 0.9961047942545476 34 Q14566 1 |
| Cell cycle 0.2135103880952628 0.109846179621483 0.912531366571732 1.0 0.9971153791594862 59 P33991,Q9Y619,Q9Y6D9,Q99640,Q14566,P11802,P06493,Q9Y3B8,Q13535,O75419,Q8WVM7,Q9UQE7,P49736,Q9UJX4 14 |
| Nonsmall cell lung cancer 0.2600500734887193 0.0902187919860992 0.9281133513768702 1.0 1.0 18 P31751 1 |
| Onecarbon metabolism and related pathways 0.2796629654838533 0.085597717015966 0.9317862133575698 1.0 1.0 13 P35790 1 |
| Mfap5 effect on permeability and motility of endothelial cells via cytoskeleton rearrangement 0.3010167297726002 0.0840396566189393 0.9330249018525528 1.0 1.0 6 Q07157,P12814 2 |
| Micrornas in cardiomyocyte hypertrophy 0.2488218343170266 0.0743722248490118 0.9407142089410612 1.0 1.0 21 P50750,Q13464,P42345,Q9P2K5,P31751 5 |
| Glucocorticoid receptor pathway 0.2937979778364837 0.0657283677398881 0.9475940870517428 1.0 1.0 6 Q86UP2 1 |
| Egfr tyrosine kinase inhibitor resistance 0.2507147382032477 0.0547861153606834 0.9563088621258432 1.0 1.0 18 P31751 1 |
| Integrinmediated cell adhesion 0.224052250511488 0.0510849970570841 0.9592577909968332 1.0 1.0 27 P62993,P31751 2 |
| Translation inhibitors in chronically activated pdgfra cells 0.2415047610448726 0.0364848380137201 0.9708957681730372 1.0 1.0 20 P31751 1 |
| Nad metabolism sirtuins and aging 0.2656875200202416 0.0268055848094881 0.9786147987860744 1.0 1.0 5 P43490 1 |
| Mirna regulation of prostate cancer signaling pathways 0.2649806681059216 0.0160628921035503 0.9871842175050012 1.0 1.0 10 P42345,Q8NCF5,P62993,P35222 4 |
| Initiation of transcription and translation elongation at the hiv1 ltr 0.2621257585847253 0.0152723819827339 0.9878148758990022 1.0 1.0 11 P50750,Q8IXH7,O94992 3 |
| Mitochondrial immune response to sarscov2 0.2627278993997316 0.0112015727710501 0.9910626249328628 1.0 1.0 10 Q99623,O94826,Q86UT6,Q9Y6M9 4 |
| Tcell antigen receptor tcr pathway during staphylococcus aureus infection 0.2369926748736065 0.0099233511462817 0.9920824412733285 1.0 1.0 18 O95433 1 |
| T cell receptor and costimulatory signaling 0.2629673100063622 0.0048227403416105 0.9961520248572366 1.0 1.0 8 P48729,Q08209,Q15118 3 |
| Mechanoregulation and pathology of yaptaz via hippo and nonhippo mechanisms 0.260602725395169 0.003031042924033 0.997581581350875 1.0 1.0 9 Q13188,P35222,Q13153 3 |
| 4hydroxytamoxifen dexamethasone and retinoic acids regulation of p27 expression 0.2606952395282653 0.0006352662664343 0.9994931308881054 1.0 1.0 8 Q13131 1 |
|
|
